Literature DB >> 18552396

Scleral hydraulic conductivity and macromolecular diffusion in patients with uveal effusion syndrome.

Timothy L Jackson1, Ali Hussain, Ana M S Morley, Paul M Sullivan, Andrea Hodgetts, Austen El-Osta, Jost Hillenkamp, Stephen J Charles, Richard Sheard, Tom H Williamson, Anupma Kumar, D Alistair H Laidlaw, W Hong Woon, Mark J Costen, Andrew J Luff, John Marshall.   

Abstract

PURPOSE: To determine whether uveal effusion syndrome (UES) is caused by altered scleral permeability to water and large molecules.
METHODS: Transscleral water movement was measured using surgically removed sclera clamped in a modified Ussing chamber and connected to a water column set at intraocular pressure. Sclera was also clamped between two hemichambers, and transscleral diffusion of FITC-dextrans (4.4-77 kDa) was measured with a spectrophotometer. Clinical data were prospectively collected using postal questionnaires.
RESULTS: Ten patients (mean age, 63 years; mean spherical equivalent, +4.7 D) had a median preoperative visual acuity of 0.20 that improved to 0.33 after surgery. Nine eyes showed visual improvement, three worsened, and two were unchanged. Histology showed disorganization of collagen fibrils, with amorphous deposits expanding the interfibrillary spaces. The mean thickness (+/-1 SD) of the excised scleral specimens was 585 +/- 309 microm, and the mean specific hydraulic conductivity was 23.9 +/- 27.5 x 10(-14) cm(2), compared with 5.8 +/- 3.9 x 10(-14) cm(2) in age-matched control specimens (P = 0.068). Three specimens had hydraulic conductivity above the 95% CI of the controls. Control eyes showed a significant reduction in diffusion coefficient (D) with age. Eyes had a mean D of 5.69 +/- 5.35 x 10(-8) cm(2) x s(-1), similar to control eyes (6.14 +/- 2.40 x 10(-8) cm(2) x s(-1), 20 kDa dextran). In one eye, the result was higher than the 95% CI of the control; in three, it was lower.
CONCLUSIONS: UES is not caused by reduced scleral hydraulic conductivity, which tends to be higher than expected. Reduced macromolecular diffusion may impede the normal transscleral egress of albumin with subsequent osmotic fluid retention in some, but not all eyes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18552396     DOI: 10.1167/iovs.08-1980

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  15 in total

1.  [Choroidal tumor with exsudative retinal detachment?].

Authors:  T Brauns; F Höhn; L-O Hattenbach
Journal:  Ophthalmologe       Date:  2012-02       Impact factor: 1.059

2.  Relationship of stokes radius to the rate of diffusion across Bruch's membrane.

Authors:  Astrid Zayas-Santiago; Alan D Marmorstein; Lihua Y Marmorstein
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-01       Impact factor: 4.799

3.  Uveal effusion syndrome mimicking severe chronic posterior uveitis: a case series of seven eyes of four patients.

Authors:  Emilia Maggio; Antonio Polito; Guido Prigione; Grazia Pertile
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-09-16       Impact factor: 3.117

4.  Medical therapy for uveal effusion syndrome.

Authors:  B Andrijević Derk; G Benčić; V Corluka; M Zorić Geber; Z Vatavuk
Journal:  Eye (Lond)       Date:  2014-06-06       Impact factor: 3.775

Review 5.  Unconventional aqueous humor outflow: A review.

Authors:  Mark Johnson; Jay W McLaren; Darryl R Overby
Journal:  Exp Eye Res       Date:  2016-02-02       Impact factor: 3.467

6.  Alteration of the serine protease PRSS56 causes angle-closure glaucoma in mice and posterior microphthalmia in humans and mice.

Authors:  K Saidas Nair; Mounira Hmani-Aifa; Zain Ali; Alison L Kearney; Salma Ben Salem; Danilo G Macalinao; Ioan M Cosma; Walid Bouassida; Bochra Hakim; Zeineb Benzina; Ileana Soto; Peter Söderkvist; Gareth R Howell; Richard S Smith; Hammadi Ayadi; Simon W M John
Journal:  Nat Genet       Date:  2011-05-01       Impact factor: 38.330

7.  A porohyperelastic finite element model of the eye: the influence of stiffness and permeability on intraocular pressure and optic nerve head biomechanics.

Authors:  Avinash Ayyalasomayajula; Robert I Park; Bruce R Simon; Jonathan P Vande Geest
Journal:  Comput Methods Biomech Biomed Engin       Date:  2015-07-21       Impact factor: 1.763

8.  Uveal Effusion Syndrome: Clinical Characteristics, Outcome of Surgical Treatment, and Histopathological Examination of the Sclera.

Authors:  Nan Zhou; Lihong Yang; Xiaolin Xu; Wenbin Wei
Journal:  Front Med (Lausanne)       Date:  2022-06-09

9.  Scleral punch method with topical mitomycin C for safe revision of failed deep sclerectomy in nanophthalmic uveal effusion syndrome.

Authors:  Nelson A Sabrosa; Henry B Smith; Robert E MacLaren
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-01-08       Impact factor: 3.117

10.  Uveal effusion syndrome in 104 eyes: Response to corticosteroids - The 2017 Axel C. Hansen lecture.

Authors:  Carol L Shields; Kelsey Roelofs; Maura Di Nicola; Kareem Sioufi; Arman Mashayekhi; Jerry A Shields
Journal:  Indian J Ophthalmol       Date:  2017-11       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.